Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial.

about

SurvivalGWAS_SV: software for the analysis of genome-wide association studies of imputed genotypes with "time-to-event" outcomes

P2860

Q36376622-D15E9DDE-8290-4AD5-BE53-617392689B6F

P2860

Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial.

Item

http://www.wikidata.org/entity/Q38981856

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Identification of SNPs associa ...... 94 randomized phase III trial.

@en

type

Item

label

Identification of SNPs associa ...... 94 randomized phase III trial.

@en

prefLabel

Identification of SNPs associa ...... 94 randomized phase III trial.

@en

P1476

Identification of SNPs associa ...... 994 randomized phase III trial

@en

P2093

A Laroche-Clary

http://www.w3.org/2001/XMLSchema#string

C Messina

http://www.w3.org/2001/XMLSchema#string

D Cameron

http://www.w3.org/2001/XMLSchema#string

H Bonnefoi

http://www.w3.org/2001/XMLSchema#string

R Bellott

http://www.w3.org/2001/XMLSchema#string

S Ait-Ouferoukh

http://www.w3.org/2001/XMLSchema#string

S Litière

http://www.w3.org/2001/XMLSchema#string

V Le Morvan

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer pharmacogenomics: strategies and challenges

under dependency

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.

MDM2, MDMX and p53 in oncogenesis and cancer therapy

The gamma 1 and gamma 2 subunits of human liver alcohol dehydrogenase. cDNA structures, two amino acid replacements, and compatibility with changes in the enzymatic properties.

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.

A simple p53 functional assay for screening cell lines, blood, and tumors.

Interactions between genetic polymorphisms in the apoptotic pathway and environmental factors on esophageal adenocarcinoma risk

Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation

A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans.

P2888

tpj.2014.24

P304

63-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/TPJ.2014.24

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jacques Robert

P577

2014-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002928230

http://www.w3.org/2001/XMLSchema#string

P698

24958282

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial.

about

P2860

P2860

Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921